MedPath

Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes

Not Applicable
Completed
Conditions
Diabetes
Diabetes Mellitus, Non-Insulin-Dependent
Interventions
Other: rehabilitation exercise intervention
Other: placebo control group
Registration Number
NCT01393275
Lead Sponsor
University of Giessen
Brief Summary

The purposes of the study are

* to determine if a supervised exercise intervention is improving the metabolic parameters in type 2 diabetes patients

* to investigate what kind of intervention (strength endurance training versus combined strength endurance training and rehabilitation exercise intervention)is more effective in improving the metabolic parameters in patients with type 2 diabetes

* to assess which exercise intervention induces higher effects to the metabolic rate and cardiac and pulmonary capacity

* to investigate what kind of intervention includes highest effects in long term persistence of these positive effects

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • diagnosis of type 2 diabetes (ADA criteria)
  • admitted diabetes treatment will be diet and oral hypoglycemic agents
Exclusion Criteria
  • sports intervention > 60 minutes per week

medical conditions

  • proliferative retinopathy
  • instable coronary heart disease
  • acute clinically significant intercurrent disease
  • inability to perform scheduled physical activity programs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Rehabilitation intervention grouprehabilitation exercise interventionThe group is performing a strength endurance training intervention in addition with rehabilitation exercise intervention.
Placebo rehabilitationplacebo control groupThe group is performing a strength endurance training intervention in addition with placebo rehabilitation exercise intervention.
Primary Outcome Measures
NameTimeMethod
alteration of HbA1c-level (haemoglobin A1c)6 months
Secondary Outcome Measures
NameTimeMethod
alteration of total cholesterol level6 months
alteration of LDL-cholesterol-level6 months
alteration of HDL-cholesterol-level6 months
alteration of triglyceride-level6 months
alteration of antidiabetic medications6 months
alteration of anthropometry6 months

body weight; body mass index; hip-to-waist-ratio

alteration of body composition6 months

measured by Bio-impedance analysis

alteration of resting metabolic rate6 months

1. measured by Spirometrie (Cortex metamax)

2. calculated by Bio-impedance analysis (TANITA)

alteration of blood pressure6 months
alteration of cardiac and pulmonary capacity6 months

1. measured by ergometry

2. six-minutes walk test

alteration of quality of life6 months
follow up of all parameters mentioned above15 months

follow up after 15 months without any supervised intervention

Trial Locations

Locations (2)

University of Giessen

🇩🇪

Giessen, Hessen, Germany

Sportpark Zwickau, Glauchau, Meerane

🇩🇪

Zwickau, Sachsen, Germany

© Copyright 2025. All Rights Reserved by MedPath